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ABSTRACT
Introduction Unfortunately, like many other health 
risks, smoking rate has been on the rise in developing 
countries. Half of current smokers in the world reside 
in only three countries of Asia that include India. Many 
smoking cessation interventions that were developed and 
successfully implemented in the context of developed 
countries have not been equally successful in South Asia. 
Hence, there is a dire need of culturally relevant smoking 
cessation interventions. We propose a scoping review with 
objectives to explore the extent and nature of interventions 
for smoking cessation and its associated factors in South 
Asian Region by systematically reviewing the available 
published and unpublished literature.
Methods and analysis The review has been registered 
in Joanna Briggs Institute (JBI) systematic reviews register 
and details are given in the Methodology section. The 
updated framework of JBI for scoping review methodology 
will be used as guide for conduct of this scoping review. 
Electronic databases (PubMed, CINAHL plus, Proquest 
Theses and Dissertations, EBSCO Dentistry and Oral 
Sciences, and Wiley Cochrane Library), reference lists of 
selected studies and grey literature will be considered for 
inclusion in this review. The literature search is anticipated 
to be carried out in December–January 2020. Initially, 
two reviewers in consultation with a librarian will develop 
search syntax followed by search from the selected 
sources. Consequently, the reviewers will screen all the 
titles, abstracts and full articles to establish relevance 
of each study for inclusion. Factors associated with 
smoking cessation will be coded and categorised applying 
qualitative content analysis, while interventions extracted 
from the literature will be described with the stated level of 
effectiveness.
INTRODUCTION
Globally, in a year over 6 million people die 
due to causes related to tobacco use. This 
number is anticipated to reach approxi-
mately 8.3 million/year by 2030, primarily 
due to increasing prevalence of tobacco use 
in low- income and middle- income coun-
tries.1 2 The increasing prevalence of cigarette 
smoking and its hazardous consequences are 
documented extensively. It is estimated that, 
globally, 942 million men and 175 million 
women over age 15 years are daily smokers; 
consequently, cigarette smoking is the single 
leading cause of preventable diseases and 
deaths making it a critical public health 
challenge.3 4Cigarette smoking leads to a 
range of health problems that either affect 
the quality of life or become the reason for 
premature death. Smoking tobacco exposes 
the smoker’s body to over 7000 toxic chem-
icals that include a minimum of 70 carcin-
ogens affecting almost every body system.3 
Significant health problems due to smoking 
include cardiovascular (mainly coronary 
heart) diseases and respiratory diseases, 
mainly cancer.5 6 Moreover, smoking is a risk 
factor for congenital disorders in the case of 
pregnant smokers, stroke, peripheral vascular 
diseases, cerebrovascular disease, renal 
failure, intestinal ischaemia and impotence 
to name a few.3 7 Furthermore, although the 
consequences of smoking are largely associ-
ated with the number of cigarettes smoked, a 
lifelong regular smoker loses approximately 
10 years of life to smoking.3 Of importance 
are the benefits of non- smoking or smoking 
Strengths and limitations of this study
 ► The review includes content in any language with 
English translation available and search in three 
different ways from South Asian Region (SAR), thus, 
increasing the chances of covering a broader range 
of work done on phenomena of interest.
 ► Most of the team members in this review are ex-
perts of systematic reviews who will ensure each 
step carried out with utmost accuracy.
 ► One of the strengths of this review is engagement of 
stakeholders and relevant organisations during the 
review process.
 ► The quality of included studies will not be ensured 
through an established tool, although some more re-
cent scoping review protocols have used tools such 
as the Newcastle–Ottawa Scale.
 ► Literature published in languages other than English 
will not be included that may affect the scope of 
the review. However, preliminary search shows 
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cessation. Quitting before age 40 years saves about 9 years 
of life because cessation at this age reduces the risk of 
death due to smoking- related morbidities by 90%.3 A 
smoker can also benefit from smoking cessation even 
after the development of smoking- related diseases such 
as chronic obstructive pulmonary diseases and cardiovas-
cular diseases.8
Hence, smoking is likely one of the most lethal and 
prevalent yet preventable health risk behaviours in today’s 
world. Its increasing epidemic levels should catalyse the 
need for better smoking cessation measures.
Definitions of terms
Smoker
Smoker is defined as a person who smoked at least once 
daily in the last 30 days.
Smoking cessation rate
Smoking cessation rate (outcome measure) in this study 
is defined as the decrease in number of cigarettes per day 
in comparison with the pre- intervention phase.
Smoking cessation intervention
Any action intended to increase cigarette smoking 
cessation rate will be referred as smoking cessation 
intervention.
South Asian Region
South Asia is one of the most populated geographical 
regions inhabited by almost a quarter of the world’s 
population.9 South Asian Region (SAR) includes Paki-
stan, India, Sri Lanka, Afghanistan, Bangladesh, Nepal, 
Bhutan and Maldives.10 Three of the countries (Paki-
stan, India and Bangladesh) mentioned in the above list 
are partition of one country, that is, British India,9 thus, 
sharing numerous cultural and religious traits. Besides, a 
common issue faced by people in countries of SAR is their 
lack of awareness of different health risks and low level of 
education. Sreeramareddy et al found that in two of the 
countries in SAR (ie, Bangladesh and Maldives), one in 
three men between 15 and 49 years is not educated, while 
17.1%–56.2% women of aged 15–49 years were unedu-
cated.11 The study also emphasised on negative associa-
tion of education level with smoking behaviour.11
Smoking is the most common health risk found high in 
South Asian population.1 2 A study on Asian population 
reports that serving tobacco products is a cultural norm 
and dignity of Asian people.12 Concurrently, the study 
by Sreeramareddy et al found the prevalence of smoking 
among men aged between 15 and 49 years as 60% in 
Bangladesh, 47.3% in Maldives, 34.1% in India, 33.6% in 
Nepal and 31.6% in Pakistan.11 The study also concluded 
that smoking in South and Southeast Asian countries is 
more common among men from low economic back-
grounds, uneducated or residents of rural areas.11 
Therefore, consideration of the context- specific factors 
associated with smoking is important in planning strate-
gies for prevention and control of cigarette smoking.
Study rationale
Despite claims by different countries regarding prog-
ress towards achievement of their smoking cessation 
goals, globally the decline in smoking prevalence has 
been slower in the last 10 years (2005–2015) than in the 
past (1990–2005).13 In developed countries, efforts for 
smoking cessation remained quite effective due to factors 
like good public awareness, availability of resources 
for smoking cessation and uniform policies towards 
smoking cessation; whereas, in low- income and middle- 
income countries, the smoking cessation rate remained 
discouraging.14–16 Consequently, if the current situation 
sustains, as predicted, by 2030, almost 80% of tobacco- 
related deaths will be in low- income and middle- income 
countries.17
Although systematic reviews either based on data from 
one specific country18 or general global data19 have been 
carried out, no review of smoking cessation interventions 
in SAR countries has been conducted on smoking cessa-
tion and its associated factors. The strict inclusion criteria 
of previously conducted systematic reviews might have 
significantly reduced the inclusion of available data on 
the phenomena of interest. Therefore, a scoping review is 
proposed with primary outcome to summarise the current 
scope of interventions and critical factors to be consid-
ered while planning any smoking cessation intervention. 
This will help in achieving secondary outcome, that is, 
to enhance effectiveness of the developing strategies for 
reduction of smoking prevalence in SAR. Moreover, the 
increasing prevalence of smoking in SAR signifies the 
imperative for reconsideration of the strategies imple-
mented for smoking cessation in this region. Therefore, 
it is important to explore the range and nature of these 
strategies to align them, through further research, with 
local contextual factors to potentiate achievement of 
optimal outcomes.
Why a scoping review?
Scoping review is an approach that covers underpinning 
concepts surrounding the phenomenon of interest20 
thus, giving a broader image that serves as a precursor 
to systematic reviews.21 Also, scoping reviews give depth 
and breadth of the research work done on a topic, 
thus increasing the understanding of the nature of the 
phenomenon under investigation.22
Effective interventions to stop or control the current 
pattern of smoking are emerging and evolving constantly. 
Due to this variability and complexity, there is a need 
to collate evidence related to interventions for smoking 
cessation among South Asian population and distin-
guishing the underpinning forces that encourage or 
discourage the behaviour of smoking. Given the range 
of programmes, national initiatives/policies and poten-
tial interventions, it is desirable that the least restrictive 
design for a review be selected to maximise the diversity 
for smoking cessation strategies in SAR. We want to take 
into account the cultural specific measures or interven-
tions which are not formally reported or not publicly 
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available. Additionally, in this study we are not focusing 
on a clinical question which would more closely align with 
a systematic review, whereas, the scoping review is more 
aligned with mapping the evidence related to the types 
of smoking cessation interventions and the characteristics 
of individuals accessing such programmes.21 After consid-
eration, a scoping review was deemed as best serving the 
aim of this study.
METHODOLOGY AND ANALYSIS
The title of this protocol has been registered with 
‘Joanna Briggs Institute (JBI) systematic review register’ 
page 10, on 28 January 2020 and can be found on their 
website (https:// jbi. global/ systematic- review- register? 
combine=& items_ per_ page= 10& page= 17& order= title& 
sort= asc).
Besides, the conduct and reporting of the scoping 
review report will be guided by the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses (PRISMA) 
extension for Scoping Review as recommended in litera-
ture.23 24 Moreover, to advance the development process 
and reporting of this protocol, the recommended 
PRISMA- Protocols checklist was used25 (attached as 
online supplemental appendix 1). In addition, the record 
and data of the review will be saved in a computer and in 
a hard drive for back- up. Also, the computer files will be 
connected to campus cloud in order to secure the data.
This review will be part of a multiphasic mixed- method 
research to include contextually relevant smoking cessa-
tion interventions and associated factors that will help 
in the development of a model for smoking cessation 
in SAR. Since the review is from existing published and 
publicly available literature, it does not require an ethical 
approval. A tentative timeline for the conduction of the 
review is attached as online supplemental appendix 2.
Patient and public involvement
This review will not include any research participants or 
patients for data collection. The stakeholders’ involve-
ment in initial planning and research question setting 
will be acknowledged in the original report of the review 
as per their permission. Moreover, the findings of the 
proposed review will be disseminated to smokers and 
relevant stakeholders to encourage their involvement in 
further planning for smoking cessation.
Protocol design
The JBI guidelines proposed by Peters et al24 underpinned 
by the framework presented by Arksey and O’Malley20 
and Levac et al26 will guide the scoping review to examine 
the extent and nature of work done on smoking cessa-
tion in SAR with the factors impacting these efforts. 
Thus, the review will be carried out in the nine stages 
mentioned herein. Also, we have experts in our team who 
have worked on topic of the scoping review. In addition 
to that, we will consult a smoking cessation consultant 
(JA) available in our university. The stated expertise will 
be instrumental in how to conduct an informed search, 
review and synthesis process.
Stage 1: defining and aligning the objective/s and question/s
The scoping review is planned to systematically search 
literature across the range and nature of interventions 
for smoking cessation and to map the factors associated 
with such interventions. Following this, questions for the 
proposed scoping review are designed as: what is known 
from existing literature about the range of interventions/
control measures devised for smoking cessation in SAR? 
and What are the factors associated with smoking cessa-
tion in SAR in the available literature?
Stage 2: developing and aligning the inclusion criteria with the 
objective/s and question/s
Aligned with the questions and objectives of the review, 
studies regardless of design including qualitative studies, 
randomised controlled trials, quasi- experimental studies, 
case–control studies, cohort studies, or descriptive studies 
addressing the phenomenon of smoking cessation or 
intervening smoking behaviour or factors associated with 
smoking cessation or combination of one or more of 
these phenomena will be included. The target population 
of the included studies will be adults (age above 18 years) 
from any country in SAR. Literature written in English or 
any other language with English translation available will 
be included. Furthermore, due to rich availability of data, 
studies published within 5 years from search date will be 
included.
Studies will be excluded if not available as free full text. 
Moreover, studies having participants from any country 
other than countries in SAR will not be included.
Stage 3: describing the planned approach to evidence searching, 
selection, data extraction and presentation of the evidence
Initially, two reviewers will extensively search the selected 
databases (PubMed, CINAHL, Proquest Theses and 
Dissertations, EBSCO Dentistry and Oral Sciences, and 
Wiley Cochrane Library) for relevant qualitative and 
quantitative data on the phenomena of interest during 
the period mentioned in the timeline. PubMed is recom-
mended for inclusion in systematic/scoping reviews as it 
covers an extensive range of literature.27 Moreover, most 
of the rest are health- related literature databases; there-
fore, their inclusion in the present scoping review can add 
significant data on preventing health hazards of smoking 
through different interventions. CINAHL, on the other 
hand, is a specialised database for nursing- related liter-
ature,27 thus adding to the phenomenon from nursing 
lens and broadening the range of the data beyond posi-
tivist view.
The anticipated dates for the literature search are 
mentioned in online supplemental appendix 2. The liter-
ature search will be carried out in the four steps discussed 
below in the Search strategy section. To maintain a 
rigorous record of the searched literature, the PRISMA 
flow diagram will be used.
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Stage 4: searching for the evidence
Step 1
After a thorough discussion with research team and 
the librarian on the selection of appropriate keywords, 
controlled vocabulary and going through relevant liter-
ature, the following key terms supported by Medical 
Subject Headings (MeSH) terms, Boolean phrases 
and wildcards were considered for literature search: 
tobacco, cigarette, smoking cessation, quit, interventions, 
measures, strategies and South Asian Region. Conse-
quently, a nested search syntax was developed as, (Inter-
vention* OR measure* OR strateg* OR program) AND 
(“Smoking”[Mesh] OR smok* OR Tobacco OR Nicotine 
OR Cigarette) AND (“Smoking Cessation”[Mesh:NoExp] 
OR Cessation OR Quit*) AND (“South Asia*” OR Paki-
stan OR Afghanistan OR Bangladesh OR Bhutan OR 
India OR Nepal OR Maldives OR Sri Lanka). The filters 
applied included full- text articles and publications in 
the last 5 years. The mentioned key terms were used to 
develop full strategy for search in PubMed (attached as 
figure 1 in image). 
Step 2
The reference list of selected articles will be manually 
checked and identified relevant references will be used 
for additional article retrieval through citation chaining. 
This will also assist in identifying relevant organisational 
websites in SAR.
Step 3
Hand searching of print journals will be carried out in 
order to capture the literature available in library that 
might have been missed while searching through selected 
search engines. 
Step 4
Data received through coordination with other research 
colleagues or key informants, information printed in 
alternate formats (ie, reports, briefs), and any available 
unpublished material will be sought and reviewed for 
relevancy to the intent of this review. Unpublished litera-
ture search will be supported through email contacts with 
authors of published articles to share any source of grey 
literature. Moreover, we will access Proquest Theses and 
Dissertations Database, OpenGrey database and Higher 
Education Commission Research Repository. Also, we will 
use the WHO country reports on cigarette smoking.
Stage 5: selecting the evidence
Based on relevance, accessed studies will be considered 
for inclusion through EndNote software. Initially, two 
reviewers will independently read the title and abstract 
of a retrieved study. Based on relevancy, the reviewers will 
recommend, include or exclude. Then, individually, the 
reviewers will read the included full- length articles and 
independently rate the appropriateness of the article 
or any reading material for inclusion. The reviewers 
will then cross check the list of included and excluded 
studies. If any discordance occurs respecting inclusion or 
exclusion of any full- text article or any other material (eg, 
reports, brief and so on) selected at the preliminary stage, 
the article or other material will be reread; and if still 
not clear to include or exclude, a third reviewer will be 
involved to build consensus. The appropriateness of the 
selected material will be based on inclusion criteria and 
authenticity of the publishing authority or of the organi-
sation to which unpublished work is associated.
Stage 6: extracting the evidence
Data will be collected using a study instrument devel-
oped by researchers that include, but not limited to, 
study reference, location, participants’ characteristics 
(ie, age, gender and ethnicity), methodology, research 
purpose, data collection and main relevant outcomes. 
This analytical form will be pretested and discussed with 
Figure 1 PubMed search conducted in November 2020.
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research team to ensure it is capturing all relevant infor-
mation (numerical data and narrative accounts) from a 
selected study. Quality assessment of included literature 
will not be performed as the intent of scoping review is 
to examine the breadth and depth of a phenomenon and 
not to check the robustness of the selected studies.20 28 At 
this stage, both the reviewers will share the extracted data 
sheets filled from the included articles.
Stage 7: analysis of the evidence
The scoping reviews aim to develop a map of the under-
pinning concepts of the selected research area, the formu-
lation of results leads to the range of work being done.27 
The proposed review will extract the extent and nature of 
work done for smoking cessation as well as the range of 
factors that might have affected such work. Furthermore, 
the review will not weigh or assess the impact of the inter-
ventions on smoking cessation as they all will be taken 
into consideration to further guide the linear analysis 
process described here. In the proposed scoping review, 
the extracted interventions will be coded based on the 
Framework Convention on Tobacco Control set forth by 
the WHO,29 and the smoking cessation- associated factors 
will be coded thematically. All the factors that have been 
described in selected studies, reports or briefings will be 
colour coded. Based on the nature of codes, they will be 
put under relevant categories, such as personal factors, 
social factors and so forth. Finally, according to the focus 
of categories, themes will be assigned to make it more 
comprehensible.
To clarify the results, quantitative and qualitative 
studies will be synthesised separately. First, individually, 
both reviewers will summarise findings from all included 
studies. Second, the reviewers will discuss their findings 
and will merge them. Findings will then be shared with 
the whole research team including the supervisor of the 
study.
To minimise bias arising from personal values, precon-
ceptions and judgements, the reviewers will undertake 
bracketing before data collection. The review process 
will involve two or more members of the research team 
in conducting the reviews in order to ensure capturing/
revealing multiple perspectives. Moreover, reviewers will 
maintain a diary to capture their feelings and learning 
experience in real time. In order to keep an organised 
and detailed record of reflexive bracketing, an iterative 
process of reflexive journey will be maintained throughout 
the review process.30 Through these strategies, we believe 
reflexivity will be achieved.
Stage 8: presentation of the results
The findings of this review will be presented in tables, 
appropriate diagrams and texts. The findings of the 
review will be shared through publications, posters, 
conference presentations and meetings with different 
stakeholders.
Stage 9: summarising the evidence in relation to the purpose of 
the review, making conclusions and noting any implications of the 
findings
Based on the findings, inferences will be drawn for presen-
tation of the whole scenario with clarity and brevity. More-
over, recommendations will be set forth to make effective 
use of the findings in future planning for smoking cessa-
tion in SAR.
Ethics and dissemination
The study does not require an ethical approval. However, 
every effort will be put to maintain transparency in the 
conduct of the study. The results of this scoping review 
will be disseminated through publications, presentations 
in conferences and meetings with stakeholders.
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